Fig. 1From: Homogeneous liquid–liquid microextraction coupled with HPLC/DAD for determination of nirmatrelvir and ritonavir as COVID-19 combination therapy in human plasmaChemical structures of nirmatrelvir, ritonavir, and velpatasvirBack to article page